New insulin boosts artificial pancreas performance in type 1 diabetes trial
Disease control
Completed
This study tested whether a faster-acting insulin (Lyumjev) works better than standard insulin (Humalog) in a dual-hormone artificial pancreas for people with type 1 diabetes. Twelve adults who already used the artificial pancreas took part. Each person used both insulins for 30 …
Phase: NA • Sponsor: Inreda Diabetic B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC